期刊文献+

肝脏5-羟色胺相关系统与肝脏疾病 被引量:1

Hepatic Serotonin-Related System and Liver Disease
下载PDF
导出
摘要 本文综述了肝脏5-羟色胺相关系统与肝损伤、肝再生、非酒精性脂肪肝及非酒精性脂肪性肝炎的关系,展望了5-羟色胺受体、转运体等作为新型治疗肝脏疾病的作用靶点的潜力。 This paper mainly reviews the relationship between hepatic 5-HT-related system and liver injury, liver regeneration and nonalcoholic fatty liver disease, and prospects that 5-HT receptors and serotonin transporters may be classes of potential new targets for treatment of liver diseases.
出处 《药学与临床研究》 2012年第1期63-66,共4页 Pharmaceutical and Clinical Research
关键词 5-羟色胺 5-羟色胺受体 5-羟色胺转运体 单胺氧化酶 肝脏疾病 5-HT 5-HT receptors Serotonin transporter Monoamine oxidase Liver disease
  • 相关文献

参考文献8

二级参考文献115

共引文献51

同被引文献37

  • 1于建勋,赵玉贞,刘淑娴,文乾亨,扬世杰,孙虓.胃癌患者胃液中5-羟色胺含量的检测及临床意义[J].白求恩医科大学学报,1990,16(4):376-378. 被引量:1
  • 2方艺,于燕妮,胡军.胃泌素和5-羟色胺的表达与胃癌临床分期及分化程度的相关性研究[J].中国医师进修杂志,2006,29(10):4-5. 被引量:3
  • 3Fava M, Kendler KS. Major depressive disorder [J]. Neuron, 2000,28(2) :335-341. 被引量:1
  • 4Filip M, Bader M. Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system [J]. Pharmacol Rep, 2009,61 (5) :761-777. 被引量:1
  • 5Drummond PD. Effect of tryptophan depletion on symptoms of motion sickness in migraineursj J], Neurology, 2005,65(4) :620.Q22. 被引量:1
  • 6Clada P, Puig M, Amarg6s-Bosch M, et al. The therapeutic role of 5-HTIA and 5-HT2A receptors in depression [J]. J Psychiatr Neurosci, 2004 ,29( 4) :252-265. 被引量:1
  • 7Dueottet C, Griebel G, Belzung C. Effects of the selective nonpeptide corticotropin-releasing factor receptor! antagonist antalarmin in the chronic mild stress model of depression in mice[J].Prog Neuropsychopharmacol BioI Psychiatry, 2003,27 ( 4) : 625 .Q31. 被引量:1
  • 8Brea J, Castro-Palomino J, Yeste S, et al. Emerging opportunities and concern for drug discovery at serotonin 5-HT2B receptors [J]. Curr Top Med Chern, 2010,10(5) :493-503. 被引量:1
  • 9Gomez-Merino 0, Bequet F, Berthelot M, et al. Evidence that the branched-chain amino acid L-valine prevents exercise-induced release of,5-HT in rat hippocampus [J]. Int J Sports Med, 2001,22 (5) :317-322. 被引量:1
  • 10Nelson JC, Portera L, Leon AC. Are there differences in the symptoms that respond to a selective 5-hydroxytryptamine or norepinephrine reuptake inhibitor [J]. Bid Psychiatry, 2005, 57 ( 12 ) : 1535-1542. 被引量:1

引证文献1

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部